PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines

Cancer Research - United States
doi 10.1158/0008-5472.can-13-2908
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1

Journal of Immunology
AllergyImmunology
2017English

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Cancer Research
Cancer ResearchOncology
2015English

Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Despite High PD-1 Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes

Journal of Immunology
AllergyImmunology
2006English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Vaccination-Induced Functional Competence of Circulating Human Tumor-Specific CD8 T-Cells

International Journal of Cancer
Cancer ResearchOncology
2011English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

P20: Tim‐3 and CTLA‐4 Pathways Help to Regulate Decidual CD8 + T Cells Function and Maintain Normal Pregnancy

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy